Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.45 |
| ▸ | ADH1C | P00326 | 1/20 | 0.45 |
| ▸ | ADH1A | P07327 | 1/20 | 0.45 |
| ▸ | ADH4 | P08319 | 1/20 | 0.45 |
| ▸ | ADH7 | P40394 | 1/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5684592 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL28206542 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL5683936 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL4407624 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL20640390 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL17956344 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL10987570 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL10741611 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL5683987 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 | |
| SCHEMBL28271640 | 1.00 | OPRM1 (0.46) | OPRM1ADH1BADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2024-04-25 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2023-03-09 | — | — | US | claimed |
| US-20220387351-A1 | Compositions and Methods Related to Organic Oxides | Natural Extraction Systems, LLC | 2022-12-08 | — | — | US | claimed |
| US-20220387376-A1 | Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents | NATURAL EXTRACTION SYS LLC (US) | 2022-12-08 | — | — | US | claimed |
| WO-2022026960-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC | 2021-11-25 | — | — | US | claimed |
| WO-2021158714-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021087291-A1 | COMPOSITIONS AND METHODS RELATED TO ORGANIC OXIDES | Natural Extraction Systems, LLC (US) | 2021-05-06 | — | — | WO | claimed |
| WO-2021076936-A1 | COMPOSITIONS COMPRISING CANNABINOID MOLECULES THAT ARE DISSOLVED IN WATER-MISCIBLE SOLVENTS | Natural Extraction Systems, LLC (US) | 2021-04-22 | — | — | WO | claimed |
| WO-2021041637-A1 | COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN GLYCEROL | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| CN-112313221-A | Cannabinoid derivatives and conjugates and uses thereof | 比托邦制药有限公司 | 2021-02-02 | — | — | CN | claimed |
| US-20210009549-A1 | CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF | BEETLEBUNG PHARMA LTD (IL) | 2021-01-14 | — | — | US | claimed |
| WO-2019159168-A1 | CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF | BEETLEBUNG PHARMA LTD. (IL) | 2019-08-22 | — | — | WO | claimed |
| WO-2024147345-A1 | COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES | ＡＰＢ株式会社 | 2024-07-11 | — | — | WO | disclosed |
| CN-115232184-B | Ribofuranosylpyridine derivatives, pharmaceutical compositions and uses thereof | 宁波熙健医药科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-4092344-A | Cyclohexenyl resorcinol derivatives | ELI LILLY AND COMPANY (US) | 1978-05-30 | — | — | US | disclosed |
| US-4054582-A | Process for converting cis-hexahydrodibenzo[b,d]pyran-9-ones to trans-hexahydrodibenzo[b,d]-pyran-9-ones | ELI LILLY AND COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387376-A1 | Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents | CNR2, CNR1, PHOSPHO1 | OPRM1 63/4885ADH1B 1702/4885ADH1C 109/4885 |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | OPRM1 3826/4885ADH1B 1571/4885ADH1C 4690/4885 |
| US-20210009549-A1 | CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF | CNR1, GLRA1, GLRA3 | OPRM1 14/4885ADH1B 2955/4885ADH1C 564/4885 |
| US-20220387351-A1 | Compositions and Methods Related to Organic Oxides | LPO, SLCO2A1, SLCO2B1 | OPRM1 26/4885ADH1B 926/4885ADH1C 3333/4885 |
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR1, CNR2, OPRD1 | OPRM1 5/4885ADH1B 4606/4885ADH1C 1107/4885 |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | CNR2, CNR1, FAAH | OPRM1 157/4885ADH1B 495/4885ADH1C 46/4885 |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR2, CNR1, FAAH | OPRM1 12/4885ADH1B 2176/4885ADH1C 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.